SUPRIYA

Jan 24 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• DEC-QUARTER PROFIT 467.8 MILLION RUPEES

• DEC-QUARTER REVENUE FROM OPERATIONS 1.86 BILLION RUPEES

Source text: [ID:]

Further company coverage: SPRL.NS

(([email protected];;))

** Supriya Lifescience SPRL.NS rises 4.6% to 750.50 rupees

** Pharma co inaugurates new multipurpose Active Pharmaceutical Ingredients production block near Maharashtra's Chiplun

** Says new block will increase site's capacity by more than 55%

** Stock snaps three-session losing streak

** SPRL up ~139% YTD

(Reporting by Vijay Malkar)

(([email protected];))

Dec 17 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• INAUGURATES MODULE E PRODUCTION BLOCK

• NEW FACILITY DEVELOPED WITH 1.25 BILLION RUPEES INVESTMENT

Source text: ID:nBSE5Sb7gX

Further company coverage: SPRL.NS

(([email protected];;))

Dec 9 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• SUPRIYA LIFESCIENCE LTD - GETS APPROVAL FROM BRAZIL'S ANVISA FOR ESKETAMINE HYDROCHLORIDE

• SUPRIYA LIFESCIENCE - DEVELOPED TECHNIQUE FOR LOW-COST MANUFACTURING OF ATORVASTATIN

Source text: ID:nBSE3X3Dp5

Further company coverage: SPRL.NS

(([email protected];))

** Shares of Supriya Lifescience SPRL.NS climb 4% to 576 rupees; set for fifth straight session of gains

** Drugmaker's Q2 consolidated profit after tax nearly doubles to 461.5 mln rupees ($5.4 mln); rev rises ~19%

** YTD, SPRL gains 82%

($1 = 84.0775 Indian rupees)

(Reporting by Hritam Mukherjee in Bengaluru)

(([email protected];))

Oct 28 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• SUPRIYA LIFESCIENCE LTD SEPT-QUARTER PROFIT 461.5 MILLION RUPEES

• SUPRIYA LIFESCIENCE LTD SEPT-QUARTER REVENUE FROM OPERATIONS 1.66 BILLION RUPEES

Source text: ID:nBSE6xzypD

Further company coverage: SPRL.NS

(([email protected];))

** Shares of Supriya Lifescience SPRL.NS rise as much as 9.5% to 492.5 rupees, highest since April 11, 2022

** SPRL eyes fourth consecutive session of gains

** The pharma co reported a 57% rise in Q1 profit, rev from ops up 22% Y/Y

** More than 2 mln shares change hands, 4.7x its 30-day avg

** Stock up 53% so far this year vs a 32% rise in Nifty Pharma Index .NIPHARM

(Reporting by Ashna Teresa Britto in Bengaluru)

(([email protected] ; ( +91 8078332441))

May 28 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• SUPRIYA LIFESCIENCE LTD - CHANGE IN DESIGNATION OF SALONI WAGH AS MD

• SUPRIYA LIFESCIENCE LTD - CHANGE IN DESIGNATION OF SALONI WAGH AS JOINT MD

Source text for Eikon: ID:nBSE51dvXs

Further company coverage: SPRL.NS

(([email protected];))

** Shares of Supriya Lifescience SPRL.NS up 7.1% at 333 rupees, highest price since Sept. 26, 2022

** Pharma ingredients maker's Q3 profit surged 3.1X YoY

** Stock on track for best day since Dec. 22, 2023

** Stock logs most active session since Dec. 26, 2023

** Rival pure-play API makers Glenmark Life Sciences GLEM.NS and Granules India GRAN.NS also posted Q3 profit climbs

(Reporting by Varun Vyas in Bengaluru)

(([email protected]))

Feb 7 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• DEC-QUARTER PROFIT 297.9 MILLION RUPEES VERSUS PROFIT 95.2 MILLION RUPEES

• DEC-QUARTER REVENUE FROM OPERATIONS 1.40 BILLION RUPEES VERSUS 1.05 BILLION RUPEES

• APPROVED CAPITAL EXPENDITURE PLAN AT AMBERNATH SITE FOR CDMO FACILITY

Source text for Eikon: ID:nBSE706RjC

Further company coverage: SPRL.NS

(([email protected];))

Jan 5 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• RECEIVED GMP CERTIFICATION FROM ANVISA BRAZIL

• LOTE FACTORY PASSED BRAZILIAN GMP INSPECTION WITH "ZERO" OBSERVATION IN TERMS OF COMPLIANCE

Source text for Eikon: ID:nBSE1yGk7D

Further company coverage: SPRL.NS

(([email protected];;))

Nov 7 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• SUPRIYA LIFESCIENCE LTD SEPT-QUARTER PROFIT 238.8 MILLION RUPEES VERSUS 168.6 MILLION RUPEES

• SUPRIYA LIFESCIENCE LTD SEPT-QUARTER REVENUE FROM OPERATIONS 1.40 BILLION RUPEES VERSUS 1.12 BILLION RUPEES

Source text for Eikon: ID:nNSE1J0Wtz

Further company coverage: SPRL.NS

(([email protected];))

Nov 6 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• SUPRIYA LIFESCIENCE LTD SIGNS AGREEMENT WITH KALINGA INSTITUTE OF TECHNOLOGY

Source text for Eikon: ID:nNSEb92j7p

Further company coverage: SPRL.NS

(([email protected];;))

Oct 23 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• SIGNS AGREEMENT WITH KALINGA INSTITUTE OF TECHNOLOGY

• SIGNS AGREEMENT WITH KALINGA INSTITUTE OF TECHNOLOGY FOR DEVELOPMENT OF ORAL CANCER DETECTION KIT

Source text for Eikon: ID:nBSE6yL4V0

Further company coverage: SPRL.NS

(([email protected];))

** Shares of Supriya Lifesciences SPRL.NS up as much as 3.75% at 289 rupees, their highest since Nov. 7

** Drugmaker on Thursday posted a 13% climb in Q1 profit, while revenue rose more than 30%

** More than 361,000 shares changed hands by 10:23 a.m. IST, 1.2x 30-day avg

** YTD, stock is up ~20%

(Reporting by Hritam Mukherjee in Bengaluru)

(([email protected];))

** Shares of Supriya Lifescience SPRL.NS rise as much as 4.58% to 287.95 rupees, highest in nearly nine months since November 7, 2022

** Uptick after the active pharmaceutical ingredients (API) maker announces collaboration with U.S.-based consumer products firm Plasma Nutrition in protein technology

** Partnership involves exclusive technology licensing agreement for proteins; SPRL to get sole rights to manufacture and market protein supplements in India

** Trading volume is 829,958 shares as of 11:31 a.m. IST, 3.3 times the 30-day avg - Refinitiv data

** Relative strength index (RSI) has been above 70 since Wednesday, suggesting the stock may be overbought

** SPRL up 20.57% in 2023 so far, including today's move compared to 20% rise in Nifty Healthcare index .NIFHEIN

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463))

Aug 2 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• CO, PLASMA NUTRITION, INC ANNOUNCE COLLABORATION IN PROTEIN TECHNOLOGY

Source text for Eikon: ID:nBSE8QrJXc

Further company coverage: SPRL.NS

(([email protected];))

May 26 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• MARCH-QUARTER PROFIT 382.3 MILLION RUPEES VERSUS 462.1 MILLION RUPEES

• MARCH-QUARTER REVENUE FROM OPERATIONS 1.42 BILLION RUPEES VERSUS 1.81 BILLION RUPEES

Source text for Eikon: ID:nBSE3gxBk5

Further company coverage: SPRL.NS

(([email protected];))

May 24 (Reuters) - Supriya Lifescience Ltd SPRL.NS:

• SUPRIYA LIFESCIENCE LTD - EXECUTED LONG- TERM SUPPLY AND SALES AGREEMENT WITH LEADING COMPANY IN EUROPE FOR SUPPLY OF ACTIVE PHARMACEUTICAL INGREDIENT

• SUPRIYA LIFESCIENCE LTD - AGREEMENT FOR A PERIOD OF 10 YEARS

• SUPRIYA LIFESCIENCE LTD - BUSINESS POTENTIAL WOULD BE APPROXIMATELY 400 MILLION RUPEES PER YEAR AT ITS PEAK

• SUPRIYA LIFESCIENCE LTD - PEAK VOLUMES ARE EXPECTED TO HAPPEN IN FY 27

Source text for Eikon: ID:nBSE67sV64

Further company coverage: SPRL.NS

(([email protected];))